ascendis pharma glp-1 receptor agonist medications New Guidelines for Type 2 Diabetes in 2025 ascendis pharma glp-1 Weight Loss
Description
It delivers potent glycemic control while producing substantial weight loss
Clinicians can and do prescribe it off-label for weight loss, but insurance coverage and access differ between Mounjaro and Zepbound depending on your plan and diagnosis
doi: 10.1210/en.2013-1934 193 PanjwaniNMulvihillEELonguetCYustaBCampbellJEBrownTJet al
Result: high adherence, slower initiation, lower commercial upside for premium brands
The GLP-1 receptor is expressed in vivo by human metastatic prostate cancer
